The PKC inhibitor GF109203X could play a key role in reducing AURKA dephosphorylation and inducing cell cycle G2/M arrest, thus restraining the development of NE characteristics and inhibiting tumor growth in vitro [29]. Here, PRRT2 is linked to neoplasm.